Selected article for: "case fatality and severe case"

Author: Chowdhury, Onima; Bruguier, Hannah; Mallett, Garry; Sousos, Nikolaos; Crozier, Kirsty; Allman, Caroline; Eyre, David; Lumley, Sheila; Strickland, Marie; Karali, Christina S.; Murphy, Lauren; Sternberg, Alex; Jeffery, Katie; Mead, Adam J.; Peniket, Andy; Psaila, Bethan
Title: Impaired antibody response to COVID‐19 vaccination in patients with chronic myeloid neoplasms
  • Cord-id: rxalg78o
  • Document date: 2021_6_24
  • ID: rxalg78o
    Snippet: The COVID-19 pandemic has had a severe impact on people with blood cancers. Patients with blood cancer are at an increased risk of poor outcomes after COVID-19 infection, with more severe infections and a higher case fatality rate (1-3), which may reflect immunocompromise due to their underlying disease and/or immunosuppressive treatments. As a result, regulatory approval and the subsequent rapid roll out of COVID-19 vaccines has been extremely well received by the blood cancer community.
    Document: The COVID-19 pandemic has had a severe impact on people with blood cancers. Patients with blood cancer are at an increased risk of poor outcomes after COVID-19 infection, with more severe infections and a higher case fatality rate (1-3), which may reflect immunocompromise due to their underlying disease and/or immunosuppressive treatments. As a result, regulatory approval and the subsequent rapid roll out of COVID-19 vaccines has been extremely well received by the blood cancer community.

    Search related documents:
    Co phrase search for related documents
    • Try single phrases listed below for: 1
    Co phrase search for related documents, hyperlinks ordered by date